17 February 2010 02:52 [Source: ICIS news]
SAN FRANCISCO (ICIS news)--The contract research organization (CRO) market has become the strongest growing segment in China’s pharmaceutical landscape, while not far behind the contract manufacturing organization (CMO) market gestates, said a China industry official on Tuesday.
“CROs right now are the hottest segment in the Chinese pharmaceutical outsourcing industry, and the reason is obvious: China has an abundant supply of high quality yet low cost chemists,” said Minghua Lu, CEO of eChinaChem, a US-based integrated media company for the Chinese chemical, pharmaceutical and life science industries.
Lu spoke at a day-long event at Informex ?xml:namespace>
In addition to its home-based pool of qualified chemists, many others are returning to
Meanwhile, CMOs are in the infancy stage, still emerging onto the Chinese market: “CMOs perhaps could be the next wave of growth in
To discuss issues facing the chemical industry go to ICIS connect
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections